Catalyst Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $638.40 Millions, with shareholders equity totaling $203.01 Millions.
The company employs approximately 56 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Catalyst Biosciences Inc. reported $10.84 Millions in revenue, generating net income of $-156.67 Millions.
Key financial metrics include a P/E ratio of -4.07, a price-to-book (P/B) ratio of 3.14, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CBIO.